Greenpro Capital Valuation
Is GRNQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GRNQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate GRNQ's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate GRNQ's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GRNQ?
Key metric: As GRNQ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is GRNQ's PS Ratio? | |
|---|---|
| PS Ratio | 2.7x |
| Sales | US$2.73m |
| Market Cap | US$8.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.8x |
| Enterprise Value/EBITDA | -3.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does GRNQ's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8.7x | ||
WNML.A Winmill | 8x | n/a | US$6.0m |
CWD CaliberCos | 0.2x | -11.7% | US$10.6m |
PWM Prestige Wealth | 25.5x | n/a | US$10.1m |
BAKR Baker Global Asset Management | 1.2x | n/a | US$11.4m |
GRNQ Greenpro Capital | 2.7x | n/a | US$8.6m |
Price-To-Sales vs Peers: GRNQ is good value based on its Price-To-Sales Ratio (2.7x) compared to the peer average (8.7x).
Price to Sales Ratio vs Industry
How does GRNQ's PS Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Sales vs Industry: GRNQ is good value based on its Price-To-Sales Ratio (2.7x) compared to the US Capital Markets industry average (3.3x).
Price to Sales Ratio vs Fair Ratio
What is GRNQ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.7x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate GRNQ's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
IX
JP¥108.63
7D
-2.1%
1Y
19.6%
Federal Home Loan Mortgage
US$9.7b
Operates in the secondary mortgage market in the United States.
FMCC
US$3.29
7D
49.0%
1Y
422.6%
VEF
SEK 2.3b
A venture capital firm specializing in early venture, emerging growth and growth capital investments.
VEFF.F
SEK 0.20
7D
0%
1Y
n/a